• Adrian Simpson, United States says, "If you are looking for a fair deal on medical supplies, IDM is something I would seriously recommend. Am hooked for life."
  • Craig, United States says, "Seemed easy to purchase, reasonable prices. Good customer service when I used it."
  • Brian Pavey, United States says, "IDM makes online shopping a pleasure. Shopping is so simple that you just breeze through it."
  • Harry Mason, United States says, "I have to admit am a bit of a lazy bloke when it comes to ordering online .And IDM pampers me to the hit as it's so simple to order."
  • John Hanks, United States says, "I was a sceptic until my first order. After, I received my first package, I turned believer. Now, it’s been 3 years since I have been ordering from IDM."
  • Natalie Wallace, United States says, "I was apprehensive about how my doubts would be addressed but what the heck,I went ahead and placed my order. Customer service was patient and helped me out."
  • Mark Penning, United States says, "Happy I got my package just in time for my vacation. Needless to say, it made my holiday a wonderfully satisfying experience."
    • Just look at what our Tens of Thousands of Satisfied Customers say about us
    Ask our pharmacist, if you have any questions related to your medications
    Click to find International Shipping charges at our pharmacy.
    Shop & Earn @ InternationalDrugMart
    Easy and secure shopping @ InternationalDrugMart.com.
    Get your instant Coupon now!
    You can find the latest happening of our pharmacy
    Follow us on Twitter

      Two New Melanoma Drugs Show Boost in Survival Rate

      Melanoma, the deadliest form of skin cancer, is on the rise, with an estimated 8,700 melanoma deaths in the United States last year. Here is a good news for people suffering from melanoma. Two novel drugs ‘Vemurafenib’ and ‘Ipilimumab’ show promise for people with advanced melanoma, which may prolong their survival.

      One study presented at American Society of Clinical Oncology (ASCO) conference stated that patients treated with the drug Vemurafenib had a 63% reduced risk of death compared with those on chemotherapy. This drug specifically targets the mutated gene and helps in the shrinking of cancer cells. Within 72 hours of intake of Vemurafenib, patients found the drug to work.

      In another study, the drug Ipilimumab has been shown to increase the survival rate in late-stage melanoma patients. This drug works by stimulating the patient’s immune system, which helps to fight against the cancer.

      Both the drugs, ‘Vemurafenib’ and ‘Ipilimumab’, shrink the tumors, and thus found to increase the survival rate of melanoma patients. Doctors have further plans to explore the best use of these drugs. It is important to note that limiting exposure to strong sunlight and UV light can reduce the risk of melanoma, the most serious form of skin cancer.

      June 07, 2011


       

      Share this Article!

    Back to top^